David Dempster

Professor

Columbia University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Dempster is a Professor at Columbia University in the United States. His research focuses on osteoporosis, bone metabolism, and related metabolic conditions, evidenced by his recent work on bone marrow adiposity, fracture incidence, and treatment strategies for postmenopausal osteoporosis. Additionally, he has contributed to studies on molecular alterations in psychosis and the impact of interleukin-6 receptor antagonists in critically ill patients. His expertise encompasses both clinical trials and meta-analyses in the field of bone health.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Felicia Cosman

Professor of Medicine

Columbia University Vagelos College of Physicians and Surgeons

UNITED STATES

View details

Eleftherios Paschalis

Ludwig Boltzmann Institute of Osteology

AUSTRIA

View details

Emma Dempster

Associate Professor

University of Exeter

UNITED KINGDOM

View details

Bruce Mitlak

Chief Medical Officer

UNITED STATES

View details

Anne Turner

Medical Research Institute of New Zealand

NEW ZEALAND

View details

Barbara Philips

University of Sussex

UNITED KINGDOM

View details

Amy Gillespie

University of Oxford

UNITED KINGDOM

View details

Nicholas James Bass

Senior Lecturer

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Dempster

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long‐Term Odanacatib Fracture Trial

Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?

Bone marrow adiposity in premenopausal women with type 2 diabetes with observations on peri-trabecular adipocytes.

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis.

Mineral and organic matrix composition at bone forming surfaces in postmenopausal women with osteoporosis treated with either teriparatide or zoledronic acid.

Effect of Teriparatide on Bone Remodeling and Density in Premenopausal Idiopathic Osteoporosis: A Phase II Trial.

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension.

Loading modality and age influence teriparatide-induced bone formation in the human femoral neck.

Collaborators (8)

Felicia Cosman

Eleftherios Paschalis

Emma Dempster

Bruce Mitlak

Anne Turner

Barbara Philips

Amy Gillespie

Nicholas James Bass

Make your next move.